mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
WZ-1-84 |
GDSC1000 |
pan-cancer |
AAC |
0.045 |
0.4 |
mRNA |
Lisitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.4 |
mRNA |
BRD-K64610608 |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.4 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
Midostaurin |
GDSC1000 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |